Mrs Megan Lawrence

Senior Medical Statistician

Connect with Megan

Publications

11 publications

Page 2 of 2

9p gain predicts outcomes in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with R-GemOx +/- Atezolizumab. ARGO: a randomised phase II study

A. Davies, P. Mckay, W. Osborne, L. Stanton, O. Tansley‐hancock, M. Lawrence, K. Mercer, A. Allen, B. Pottinger, A. Zhelyazkova, F. Miall, J. Rafferty, B. Sale, F. Cucco, L. Nunn, A. Coleman, G. Griffiths, M. Q Du, C. Burton, S. Barrons & P. Johnson, 2021, Hematological Oncology, 39(S2), 155 - 156

DOI: 10.1002/hon.11_2880

Type: conference